Special NoticePosted Sep 2, 2026·Original deadline passed (Sep 15). See latest amendment for current deadline.

Notice of Intent to Sole Source - Bioquell an EcoLab solution

CDC · CDC OFFICE OF ACQUISITION SERVICES

Stage
Early notice (sources sought, presolicitation or special notice)
NAICS
334516
Value
Not stated
Solicitation
98923
Set-aside
None stated
PSC
6640
Place
Atlanta, GA, USA
Contact
Marcus Lindsey (yzg2@cdc.gov)
Loading your pipeline and notes…
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 98923 in this department, oldest first.

Early notice
  • Sep 2, 2026 · this notice
    Special Notice
Solicitation
None posted
Award
Not yet. Too few past cases at this agency to estimate timing (2 found; 10 needed).

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Answer the notice: this is when the requirement can still be shaped.
  • Contact the contracting officer named on the notice.
  • Check who won similar work; they are the likely bidders.

What the notice says

Purchase of VHP Generators, decontamination equipment Clarus S Kit : 10068395 1 x Clarus S vaporizer 1 x Clarus S external aeration unit 1 x Clarus S internal aeration unit 1 x Clarus S control module Equipment Freight including pack and pallet Bioquell L-4 Gas Generator including: Thermal Printer, Communications port (RS485) RFID enabled Bioquell L-4 standard documentation: -User Manual -Certificate of conformity -Insulated 1.5m Hoses TD059-8100-1500 Engineering No. (10250085) Supply Hose & TD059-8200-1500 Engineering No. (10250164) Return Hose Hydrogen Peroxide sensor mount �Y� piece 1.5� Eq… (show all)

uipment freight, including pack and pallet Bioquell L-4 Validation Package 1 -On-site commissioning of Bioquell equipment -On-site performance of IOQ -Operator Training -Preparation and completion of all documentation

Recent Agency Awards (Loose Match)

111 award notices on SAM.gov in the last 24 months. Matched by: Same agency (CDC), any industry: a loose match.

Loose match: same agency, any industry. Read the titles before treating these as competitors.

Single-winner award sizes (107): middle half $242K to $7.0M, median $785K; range $14K to $4.5B.

WinnerAwardsValueLast
POLOLEI SOLUTIONS, LLC5$3.3MJul 21, 2026
GLAXOSMITHKLINE, LLC3$1.7BMar 27, 2026
RESEARCH TRIANGLE INSTITUTE Durham NC 27709 USA3$9.8MJun 4, 2026
MERCK SHARP & DOHME LLC · $MRK · $66.6B2$4.5BSep 14, 2026
Pfizer New York NY 10001 USA2$1.2BJun 3, 2026
SEQIRUS USA INC2$663.9MDec 31, 2024
Moderna Princeton NJ 08540 USA2$314.2MJun 3, 2026
SANOFI PASTEUR INC.2$233.3MDec 31, 2024
ASTRAZENECA PHARMACEUTICALS LP2$61.0MDec 31, 2024
Sanofi Swiftwater PA 18370 USA2$40.6MJun 3, 2026

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

Investor context
  • $MRK reported $66.6B revenue (12 months to Jun 30, 2026). The median single-winner award in these 107 past awards, $785K, is under 0.1% of that. SEC filing

One award's total value against one year of revenue; many awards are paid over several years.

Latest awards

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Centers For Disease Control & Prevention (CDC) since 2024 (5 filings)
  • 0 of their lobbyists list a past Centers For Disease Control & Prevention (CDC) job
  • $99K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Energy and Commerce, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor, and Pensions
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 0 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.

  • 1 of the past winners are listed companies
  • 0 insider buys and 7 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name, including the subsidiaries a company lists in its SEC filings. A company we could not match shows no market rows; that is a miss, not a finding.